Nick Calus

Title: Innovations by Nick Calus in Capacitor Testing for Implantable Stimulators

Introduction

Nick Calus is an accomplished inventor based at Macquarie University in Australia. He has made significant contributions to the field of medical technology, particularly in the area of implantable stimulators. His innovative work focuses on improving the reliability of these devices through advanced capacitor testing methods.

Latest Patents

Nick Calus holds a patent for "Capacitor testing for implantable stimulators." This patent addresses the critical need for testing capacitors to identify potentially faulty DC blocking capacitors in implantable stimulators. The disclosed examples involve selecting an active electrode, a return electrode, and a reference electrode. The method utilizes short duration monophasic stimulation to charge the DC blocking capacitors of the active and return electrodes. The electrodes are then disconnected from all other nodes except a discharge circuit and the tissue. The reference electrode measures the voltage of the DC blocking capacitor during both the charging and discharging phases. By analyzing the characteristics of the capacitors, it is possible to determine their functionality and identify any faulty components by comparing actual and expected characteristics.

Career Highlights

Nick Calus is associated with Cochlear Limited, a leading company in the field of implantable hearing solutions. His work at Cochlear Limited has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in medical technology.

Collaborations

Some of his notable coworkers include Helmut Christian Eder and Mathew Ross Markey. Their collaboration has likely fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.

Conclusion

Nick Calus's contributions to capacitor testing for implantable stimulators exemplify the importance of innovation in medical technology. His patent not only enhances the reliability of implantable devices but also showcases the potential for further advancements in this critical area.